inflammatory myofibroblastic tumor (Cancer)
Information
- Disease name
- inflammatory myofibroblastic tumor
- Disease ID
- DOID:0050905
- Description
- "A mesenchymal cell neoplasm that has_material_basis_in myofibroblastic cells admixed with inflammatory cells." [url:http\://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689747/, url:https\://www.ncbi.nlm.nih.gov/pubmed/23091756]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02180867 | Active, not recruiting | Phase 2/Phase 3 | Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery | July 11, 2014 | December 22, 2024 |
| NCT04925609 | Recruiting | Phase 1/Phase 2 | Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors | August 18, 2022 | December 2030 |
| NCT02465528 | Terminated | Phase 2 | Ceritinib Rare Indications Study in ALK+ Tumors | May 6, 2016 | August 20, 2018 |
| NCT03874273 | Unknown status | Phase 2/Phase 3 | Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors | February 1, 2019 | March 1, 2021 |
- Disase is a (Disease Ontology)
- DOID:3350
- Cross Reference ID (Disease Ontology)
- GARD:7146
- OrphaNumber from OrphaNet (Orphanet)
- 178342